基因Wmp,即Wu-Mei-Pill,是一种中药配方,用于治疗与慢性肠炎相关的结直肠癌(CAC)。Wmp的组成包括多种草药提取物,其治疗机制尚未完全清楚。根据一项研究,Wmp通过上调脂肪酸氧化PPAR信号通路相关基因的表达,抑制Wnt信号通路介导的EMT,以及下调CCL3/CCR1介导的炎症反应,从而显著抑制CAC的肿瘤发生[1]。此外,网络药理学分析揭示了Wmp在治疗溃疡性结肠炎(UC)和2型糖尿病(T2DM)中的潜在机制,包括抗氧化、抗炎和免疫调节作用[5,7]。
在神经科学领域,一项研究通过多变量全基因组关联研究(GWAS)发现,在神经影像学模态之间存在广泛的遗传重叠,这些基因主要在胎儿大脑发育期间表达,并参与调节大脑形态、功能连接和组织成分[2]。此外,基因GIGYF1的基因缺失与2型糖尿病的诊断相关,提示GIGYF1在调节胰岛素信号和保护免受糖尿病中的作用[6]。
在基因治疗领域,一项研究报道了使用转铁蛋白受体靶向的木马脂质体进行NPC1小鼠的基因治疗,通过输送编码人类NPC1开放阅读框的质粒DNA,有效地减少了脑部和周围器官中的组织包涵体[4]。另一项研究则发现,基于造血干细胞和祖细胞的慢病毒基因疗法(HSPC-LVGT)能够有效地预防MPS II小鼠模型中的脑部病理,但未能纠正软骨的病理[3]。
综上所述,基因Wmp在治疗CAC中显示出潜力,其机制可能与调节PPAR信号通路、Wnt信号通路和炎症反应有关。此外,Wmp可能具有治疗UC和T2DM的潜力,其机制可能与抗氧化、抗炎和免疫调节作用有关。在神经科学和基因治疗领域,研究揭示了遗传重叠在神经影像学模态中的作用,以及基因GIGYF1和基因治疗在糖尿病和其他疾病中的作用。这些发现为深入理解疾病发生机制和开发新的治疗方法提供了重要的线索。
参考文献:
1. Cui, Huantian, Jin, Yutong, Wang, Ning, Bian, Yuhong, Wen, Weibo. 2024. Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study. In Phytomedicine : international journal of phytotherapy and phytopharmacology, 128, 155509. doi:10.1016/j.phymed.2024.155509. https://pubmed.ncbi.nlm.nih.gov/38452403/
2. Tissink, E P, Shadrin, A A, van der Meer, D, Dale, A M, Andreassen, O A. 2024. Abundant pleiotropy across neuroimaging modalities identified through a multivariate genome-wide association study. In Nature communications, 15, 2655. doi:10.1038/s41467-024-46817-4. https://pubmed.ncbi.nlm.nih.gov/38531894/
3. Catalano, Fabio, Vlaar, Eva C, Dammou, Zina, van der Ploeg, Ans T, Pijnappel, W W M Pim. 2024. Lentiviral Gene Therapy for Mucopolysaccharidosis II with Tagged Iduronate 2-Sulfatase Prevents Life-Threatening Pathology in Peripheral Tissues But Fails to Correct Cartilage. In Human gene therapy, 35, 256-268. doi:10.1089/hum.2023.177. https://pubmed.ncbi.nlm.nih.gov/38085235/
4. Jiang, Dahai, Lee, Hungyen, Pardridge, William M. 2020. Plasmid DNA gene therapy of the Niemann-Pick C1 mouse with transferrin receptor-targeted Trojan horse liposomes. In Scientific reports, 10, 13334. doi:10.1038/s41598-020-70290-w. https://pubmed.ncbi.nlm.nih.gov/32770132/
5. Huang, Jinke, Zheng, Yijun, Ma, Jinxin, Wang, Fengyun, Tang, Xudong. 2021. Exploration of the Potential Mechanisms of Wumei Pill for the Treatment of Ulcerative Colitis by Network Pharmacology. In Gastroenterology research and practice, 2021, 4227668. doi:10.1155/2021/4227668. https://pubmed.ncbi.nlm.nih.gov/34970312/
6. Deaton, Aimee M, Parker, Margaret M, Ward, Lucas D, Baras, Aris, Nioi, Paul. 2021. Gene-level analysis of rare variants in 379,066 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes. In Scientific reports, 11, 21565. doi:10.1038/s41598-021-99091-5. https://pubmed.ncbi.nlm.nih.gov/34732801/
7. Sun, Chang, Xiao, Keyuan, He, Yinxiong, Li, Xinghua. . Common mechanisms of Wumei pills in treating ulcerative colitis and type 2 diabetes: Exploring an integrative approach through network pharmacology. In Medicine, 103, e37094. doi:10.1097/MD.0000000000037094. https://pubmed.ncbi.nlm.nih.gov/38277529/